BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27999289)

  • 1. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Utility of Flow Cytometry Analysis of Reactive T Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    David JA; Huang JZ
    Am J Clin Pathol; 2016 Jan; 145(1):107-15. PubMed ID: 26712878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.
    Rahemtullah A; Reichard KK; Preffer FI; Harris NL; Hasserjian RP
    Am J Clin Pathol; 2006 Nov; 126(5):805-14. PubMed ID: 17050078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse.
    Bein J; Thurner L; Hansmann ML; Hartmann S
    Am J Hematol; 2020 Dec; 95(12):1495-1502. PubMed ID: 32815561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
    Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
    Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry CD4(+)CD26(-)CD38(+) lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes.
    Di Gaetano R; Gasparetto V; Padoan A; Callegari B; Candiotto L; Sanzari MC; Scapinello A; Tagariello G
    Ann Hematol; 2014 Aug; 93(8):1319-26. PubMed ID: 24627194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
    Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
    Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.
    Sohani AR; Jaffe ES; Harris NL; Ferry JA; Pittaluga S; Hasserjian RP
    Am J Surg Pathol; 2011 Nov; 35(11):1666-78. PubMed ID: 21997687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Chen ZW; Wizniak J; Shang C; Lai R
    Arch Pathol Lab Med; 2022 Jun; 146(6):718-726. PubMed ID: 34506624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma.
    Rahemtullah A; Harris NL; Dorn ME; Preffer FI; Hasserjian RP
    Leuk Lymphoma; 2008 Oct; 49(10):1870-8. PubMed ID: 18949610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting.
    Fromm JR; Thomas A; Wood BL
    Am J Pathol; 2017 Feb; 187(2):304-317. PubMed ID: 27998726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
    Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
    Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
    Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
    Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
    Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
    Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.